“Test-retest reliability and minimal detectable change in TGlittre-P test in children and adolescents with cystic fibrosis”

References

• Almajed A, Lands LC. The evolution of exercise capacity and its limiting factors in Cystic Fibrosis. Paediatr Respir Rev. 2012;13(4):195–199.
   PubMed Web of Science ®Google Scholar
• Vendrusculo FM, Heinzmann-Filho JP, da Silva JS, et al. Peak oxygen uptake and mortality in cystic fibrosis: systematic review and meta-analysis. Respir Care. 2019;64(1):91–98.
   PubMed Web of Science ®Google Scholar
• Aznar S, Gallardo C, Fiuza-Luces C, et al. Levels of moderate-vigorous physical activity are low in Spanish children with cystic fibrosis: a comparison with healthy controls. J Cyst Fibros. 2014;13(3):335–340.
   PubMed Web of Science ®Google Scholar
• Nixon PA, Orenstein DM, Kelsey SF, et al. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992;327(25):1785–1788.
   PubMed Web of Science ®Google Scholar
• Pérez M, Groeneveld IF, Santana-Sosa E, et al. Aerobic fitness is associated with lower risk of hospitalization in children with cystic fibrosis. Pediatr Pulmonol. 2014;49(7):641–649.
   PubMed Web of Science ®Google Scholar
• Skumlien S, Hagelund T, Bjørtuft Ø, et al. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006;100(2):316–323.
   PubMed Web of Science ®Google Scholar
• Monteiro F, Ponce DAN, Silva H, et al. Validity and reproducibility of the glittre ADL-test in obese and post-bariatric surgery patients. Obes Surg. 2017;27(1):110–114.
   PubMed Web of Science ®Google Scholar
• Valadares YD, Corrêa K. d S, Silva BO, et al. Applicability of activities of daily living tests in individuals with heart failure. Rev Bras Med Esporte. 2011;17(5):310–314.
   Web of Science ®Google Scholar
• dos Santos K, Gulart AA, Munari AB, et al. Reproducibility of ventilatory parameters, dynamic hyperinflation, and performance in the glittre-ADL test in COPD patients. COPD J Chronic Obstr Pulm Dis. 2016;13(6):700–705.
   PubMed Web of Science ®Google Scholar
• Gulart AA, Araujo C. d, Munari AB, et al. The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease: minimal important difference for Glittre-ADL test. Braz J Phys Ther. 2020;24(1):54–60.
   PubMed Web of Science ®Google Scholar
• Martins R, Assumpção M, Mayer AF, et al. The validity and reliability of the ADL-Glittre test for children. Physiother Theory Pract. 2019;35(8):773–780.
   PubMed Web of Science ®Google Scholar
• Scalco JC, Minsky RC, Mayer AF, et al. Comparison of the physiological responses induced by different pediatric exercise field tests in children. Pediatr Pulmonol. 2019;54(9):1431–1438.
   PubMed Web of Science ®Google Scholar
• Almeida AC, Wamosy RMG, Ludwig Neto N, et al. Pediatric Glittre ADL-test in cystic fibrosis: physiological parameters and respiratory mechanics. Physiother Theory Pract. 2019;20:1–8.
   Google Scholar
• Ozipek M, Arikan H, Calik-Kutukcu E, et al. Deviations of body functions and structure, activity limitations, and participation restrictions of the International Classification of Functioning, Disability, and Health model in children with cystic fibrosis and non–cystic fibrosis bronchiectasis. Pediatr Pulmonol. 2020;55(5):1207–1216.
   PubMed Web of Science ®Google Scholar
• Gianfrancesco L, Malheiro APG, Matsunaga NY, et al. Are there differences in the physical activity level and functional capacity among children and adolescents with and without asthma? J Pediatr. 2020. DOI:10.1016/j.jped.2020.04.004
   Google Scholar
• de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–667.
   PubMed Web of Science ®Google Scholar
• Solé D, Vanna AT, Yamada E, et al. International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire: validation of the asthma component among Brazilian children. J Investig Allergol Clin Immunol. 1998;8(6):376–382.
   PubMed Web of Science ®Google Scholar
• Dal'Maso VB, Mallmann L, Siebert M, et al. Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis. J Bras Pneumol. 2013;39(2):181–189.
   PubMed Web of Science ®Google Scholar
• Coutinho CA, de AC, Marson Fa de L, Ribeiro AF, et al. Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis. J Bras Pneumol. 2013;39(5):555–561.
   PubMed Web of Science ®Google Scholar
• Kanga J, Kuhn R, Craigmyle L, et al. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther. 1999;21(8):1343–1356.
   PubMed Web of Science ®Google Scholar
• Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr. 1994;124(2):177–192.
   PubMedGoogle Scholar
• Doershuk CF, Matthew SL, Tucker AS, et al. A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosis. J Pediatr. 1964;65:677–693.
   PubMed Web of Science ®Google Scholar
• Hulley SB, Cummings SR, Browner WS, et al. Designing clinical research. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins, a Wolters Kluwer business; 2013. p.367.
   Google Scholar
• Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. Oxford (UK): Blackwell Scientific Publications; 2002. 817 p.
   Google Scholar
• Arikan H, Yatar İ, Calik-Kutukcu E, et al. A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and healthy subjects. Res Dev Disabil. 2015;45-46:147–156.
   PubMed Web of Science ®Google Scholar
• Ministry of Health. National program TELESSAÚDE BRASIL [Internet]. BVS APS Atenção Primária à Saúde. [cited 2018 Aug 9]. Available from: http://aps.bvs.br/apps/calculadoras/?page=7
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
   PubMed Web of Science ®Google Scholar
• De Medeiros T, Cavalcante C, Diccini S, et al. The use of Borg’s modified scale in asthma crises. Acta Paul Enferm. 2008;21(3):466–473.
   Web of Science ®Google Scholar
• Martins R, Gonçalves RM, Minsky RC, et al. Escala de percepção de esforço para criança (PES-C): validação para o português em um teste submáximo. Bras J Phys Educ Sport. 2018;34(3):513–522.
   Google Scholar
• Martins R, Bobbio TG, Mayer AF, et al. Reference equations for the ADL-glittre test in pediatric subjects. Respir Care. 2019 [cited 2019 Jun 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30992402
   Google Scholar
• Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–428.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (MI): Lawrence Erlbaum Associates; 1988. 82 p.
   Google Scholar
• del Corral T, Gómez Sánchez Á, López-de-Uralde-Villanueva I. Test-retest reliability, minimal detectable change and minimal clinically important differences in modified shuttle walk test in children and adolescents with cystic fibrosis. J Cyst Fibros. 2020;19(3):442–448.
   PubMed Web of Science ®Google Scholar
• López-de-Uralde-Villanueva I, Sarría Visa T, Moscardó Marichalar P, et al. Minimal detectable change in six-minute walk test in children and adolescents with cystic fibrosis. Disabil Rehabil. 2019;19:1–6.
   Google Scholar
• Beninato M, Portney LG. Applying concepts of responsiveness to patient management in neurologic physical therapy. J Neurol Phys Ther. 2011;35(2):75–81.
   PubMed Web of Science ®Google Scholar
• Furlan L, Sterr A. The applicability of standard error of measurement and minimal detectable change to motor learning research-a behavioral study. Front Hum Neurosci. 2018;12:95.
   PubMed Web of Science ®Google Scholar
• Ries JD, Echternach JL, Nof L, et al. Test-retest reliability and minimal detectable change scores for the timed “Up & go” test, the six-minute walk test, and gait speed in people with Alzheimer disease.” Phys Ther. 2009;89(6):569–579.
   PubMed Web of Science ®Google Scholar
• Yuksel E, Kalkan S, Cekmece S, et al. Assessing minimal detectable changes and test-retest reliability of the timed up and go test and the 2-minute walk test in patients with total knee arthroplasty. J Arthroplasty. 2017;32(2):426–430.
   PubMed Web of Science ®Google Scholar
• Abdelbasset WK, Soliman GS, Elshehawy AA, Alrawaili SM. Exercise capacity and muscle fatiguability alterations following a progressive maximal exercise of lower extremities in children with cystic fibrosis. Afr H Sci. 2018;18(4):1236–1242.
   PubMed Web of Science ®Google Scholar
• Papalexopoulou N, Dassios TG, Lunt A, et al. Nutritional status and pulmonary outcome in children and young people with cystic fibrosis. Respir Med. 2018;142:60–65.
   PubMed Web of Science ®Google Scholar
• De Rê A, Danielewicz AL, Mafra E, et al. Physical therapy and exercise: energy expenditure in cystic fibrosis. Pediatr Mod. 2012;48(10):397–403.
   Google Scholar
• Gulart AA, Munari AB, Klein SR, et al. The glittre-ADL test cut-off point to discriminate abnormal functional capacity in patients with COPD. COPD J Chronic Obstr Pulm Dis. 2018;15(1):73–78.
   PubMed Web of Science ®Google Scholar
• Cherobin IA, Dalcin P de TR, Ziegler B. Association between lung function, physical activity level and postural evaluation variables in adult patients with cystic fibrosis. Clin Respir J. 2018;12(4):1510–1517.
   PubMed Web of Science ®Google Scholar